Nyloxin :: Chronic Pain Relief

Archive for December, 2012

Nutra Pharma Provides Sales and Marketing Update

Nutra Pharma is providing an update on the sales and marketing efforts of TCN as they begin their global marketing campaign for Nutra Pharma’s over-the-counter (OTC) pain reliever, Nyloxin™. Coral Springs, FL. – December 20, 2012 – Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple […]

Thursday, December 20th, 2012

Nutra Pharma Introduces Nyloxin™ Military Strength

Nutra Pharma is introducing a stronger version of its over-the-counter (OTC) pain reliever, Nyloxin™, and has begun the process of registration with the United States government for sales into the military. Coral Springs, FL. – December 19, 2012 – Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV […]

Wednesday, December 19th, 2012

Nutra Pharma Letter to Shareholders

Nutra Pharma CEO, Rik J Deitsch, has published a letter to Shareholders outlining the current efforts and the future goals of the Company. December 18, 2012 — Coral Springs, Florida — Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, […]

Tuesday, December 18th, 2012

Nyloxin is a Registered Trademark of Nutra Pharma Corporation. Copyright © 2009-2011. All Rights Reserved.

Nutra Pharma Corporation